Meta‐analysis of immunonutrition in major abdominal surgery. BJS 2017; 104: 1594-1608.
Published: 22nd September 2017
Authors: P. Probst, S. Ohmann, U. Klaiber, F. J. Hüttner, A. T. Billeter, A. Ulrich et al.
The objective of this study was to evaluate the potential benefits of immunonutrition in major abdominal surgery with special regard to subgroups and influence of bias.
A systematic literature search from January 1985 to July 2015 was performed in MEDLINE, Embase and CENTRAL. Only RCTs investigating immunonutrition in major abdominal surgery were included. Outcomes evaluated were mortality, overall complications, infectious complications and length of hospital stay. The influence of different domains of bias was evaluated in sensitivity analyses. Evidence was rated according to the GRADE Working Group grading of evidence.
A total of 83 RCTs with 7116 patients were included. Mortality was not altered by immunonutrition. Taking all trials into account, immunonutrition reduced overall complications (odds ratio (OR) 0·79, 95 per cent c.i. 0·66 to 0·94;
Immunonutrition after major abdominal surgery did not seem to alter mortality (GRADE: high quality of evidence). Immunonutrition reduced overall complications, infectious complications and shortened hospital stay (GRADE: low to moderate). The existence of bias lowers confidence in the evidence (GRADE approach).Read more
You may also be interested in
Comparison of gaze behaviour of trainee and experienced surgeons during laparoscopic gastric bypass.
Authors: S. Erridge, H. Ashraf, S. Purkayastha, A. Darzi, M. H. Sodergren
Notes: Potential uses in training and assessment
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
Authors: X.‐F. Zhang, E. W. Beal, F. Bagante, J. Chakedis, M. Weiss, I. Popescu et al.
Notes: Early recurrence is bad news
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
Authors: H. Grut, S. Solberg, T. Seierstad, M. E. Revheim, T. S. Egge, S. G. Larsen et al.
Notes: Immunosuppression may not accelerate growth
Impact of weight loss and eating difficulties on health‐related quality of life up to 10 years after oesophagectomy for cancer.
Authors: P. Anandavadivelan, A. Wikman, A. Johar, P. Lagergren
Notes: Associated with deterioration of HRQOL
Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.
Authors: S. R. Markar, H. Mackenzie, T. Wiggins, A. Askari, A. Karthikesalingam, O. Faiz et al.
Notes: Improves outcome of oesophageal perforation
Authors: K. Mohkam, O. Farges, E. Vibert, O. Soubrane, R. Adam, F.‐R. Pruvot et al.
Notes: Multi‐institutionally validated prognostic tool
Meta‐analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.
Authors: K. Polom, L. Marano, D. Marrelli, R. De Luca, G. Roviello, V. Savelli et al.
Notes: Microsatellite instability subgroup does better
Randomized clinical trial
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early‐stage hepatocellular carcinoma. BJS 2017; 104: 1775-1784.
Authors: K. K. C. Ng, K. S. H. Chok, A. C. Y. Chan, T. T. Cheung, T. C. L. Wong, J. Y. Y. Fung et al.
Notes: Radiofrequency ablation is not superior
Authors: V. Wanjura, E. Szabo, J. Österberg, J. Ottosson, L. Enochsson, G. Sandblom et al.
Notes: Avoid unnecessary surgery
Meta‐analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer. BJS 2017; 104: 1609-1619.
Authors: B. Creavin, M. E. Kelly, E. Ryan, D. C. Winter
Notes: Open excision provides better‐quality mesorectum
Authors: J. Deng, J. Guo, G. Ma, H. Zhang, D. Sun, Y. Hou et al.
Notes: Identifies a poor prognosis group